Free Trial

Smith & Nephew plc (LON:SN) Insider Deepak Nath Sells 34,033 Shares

Smith & Nephew logo with Medical background

Smith & Nephew plc (LON:SN - Get Free Report) insider Deepak Nath sold 34,033 shares of Smith & Nephew stock in a transaction that occurred on Thursday, December 5th. The shares were sold at an average price of GBX 981 ($12.52), for a total transaction of £333,863.73 ($426,009.61).

Smith & Nephew Stock Down 0.6 %

Smith & Nephew stock traded down GBX 5.60 ($0.07) during mid-day trading on Friday, reaching GBX 978.80 ($12.49). The company had a trading volume of 1,910,354 shares, compared to its average volume of 343,671. The company has a current ratio of 2.51, a quick ratio of 0.84 and a debt-to-equity ratio of 70.22. The stock has a market cap of £8.53 billion, a price-to-earnings ratio of 3,625.19, a price-to-earnings-growth ratio of 0.46 and a beta of 0.62. The stock's 50 day simple moving average is GBX 1,042.88 and its 200 day simple moving average is GBX 1,075.48.

Smith & Nephew Company Profile

(Get Free Report)

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.

Featured Stories

Should You Invest $1,000 in Smith & Nephew Right Now?

Before you consider Smith & Nephew, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Smith & Nephew wasn't on the list.

While Smith & Nephew currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines